BlueWind Medical Appoints Lori Chmura as Chair of the Board
BlueWind Medical has announced the appointment of Lori Chmura as the new Chair of its Board of Directors. This decision reflects the company's dedication to innovative leadership in the area of implantable Tibial NeuroModulation (iTNM), particularly with their leading product, Revi, which targets treating urge urinary incontinence (UUI). With her extensive experience in the MedTech industry, Lori Chmura is well-suited for this important role.
Lori Chmura: A Proven Leader in MedTech
Ms. Chmura comes with over 30 years of invaluable experience across multiple key positions within the medical technology industry. Throughout her career, she has played a vital role in shaping growth strategies at a variety of venture-backed companies, and she has led crucial initiatives at major global medical device firms. Notably, she has made significant contributions to organizations such as Medtronic, Covidien, and Johnson & Johnson, where her leadership was associated with remarkable growth both regionally and internationally.
Current Role and Previous Achievements
At present, Lori serves as the Chief Executive Officer of Nyra Medical, directing the development of next-generation transcatheter mitral valve repair technology. She has also held executive positions at Soundbite Medical Solutions and Dune Medical Devices, where her strategic oversight was key in restructuring, as well as in managing licensing and acquisition agreements. Not to mention, her role on OpSens Medical's Board, leading to a successful acquisition, highlights her expertise in driving business outcomes.
Vision for BlueWind Medical
Lori Chmura's appointment is particularly timely for BlueWind Medical as the company strives to extend the reach of the Revi therapy. CEO Dan Lemaitre expressed his excitement in having Chmura join the board, emphasizing her wealth of experience in bringing MedTech innovations to market. He believes her insights will play a crucial role in advancing BlueWind’s mission to improve the lives of patients living with UUI, thereby granting them access to life-changing therapies.
Strategic Goals and Innovations
BlueWind Medical is committed to transforming neuromodulation therapies by introducing patient-focused medical technologies. The Revi System, which offers a unique approach to treating UUI, combines a simple implant procedure with a user-friendly external wearable device. This device customizes therapeutic interventions to meet the specific needs of each patient. This patient-centric approach distinguishes BlueWind, giving clinicians the flexibility to assess the suitability of the Revi System on a case-by-case basis.
About BlueWind Medical
BlueWind Medical is focused on revolutionizing the field of neuromodulation therapy. The company aims to develop innovative, patient-centered solutions that tackle significant healthcare challenges, starting with urge urinary incontinence. With Revi, patients can access a safe and effective treatment alternative designed to enhance their quality of life. BlueWind’s innovation strategy prioritizes evidence-based therapies that adapt to the individual needs of patients, rather than sticking to rigid treatment protocols.
Frequently Asked Questions
Who is Lori Chmura and what role has she been appointed to?
Lori Chmura has been appointed as the Chair of the Board of Directors at BlueWind Medical, bringing a wealth of experience from the MedTech sector.
What is BlueWind Medical known for?
BlueWind Medical is recognized for pioneering work in implantable Tibial NeuroModulation (iTNM) and developing the Revi device aimed at treating urge urinary incontinence.
What previous roles has Lori Chmura held?
Before her role at BlueWind Medical, Lori Chmura held leadership positions at Nyra Medical, Soundbite Medical Solutions, and Dune Medical Devices.
How does the Revi System work?
The Revi System presents a new treatment strategy for urge urinary incontinence, featuring a safe, implantable device tailored to individual patient therapy.
Why is Lori Chmura's experience important for BlueWind?
Her vast experience in commercializing MedTech innovations and facilitating business transformations will be essential for driving BlueWind Medical's mission and enhancing access to Revi therapy for patients.
